Category: News

World Renowned Eye Expert Dr. José-Alain Sahel, M.D. Joins Advisory Board of Ichor Therapeutics, Inc.

Written by Welcome on May 8, 2017

Will Advise on Clinical Trial Design for Dry AMD and Stargardt’s Treatment LaFayette, NY – Ichor Therapeutics, Inc. (Ichor Therapeutics) is pleased to announce that it has recruited one of the world’s top experts in retinal disease, Dr. José-Alain Sahel, M.D., to join its Advisory Board regarding LYSOCLEAR™, a pre-clinical drug candidate in development by […]

Ichor Therapeutics announces series A offering for LYSOCLEAR to move first SENS therapy into the clinic

Written by Welcome on February 15, 2017

  February 15th, 2017 LAFAYETTE, NY: Today, Ichor Therapeutics, a biotechnology company that focuses on developing drugs for age-related diseases, announced a series A offering to bring its LYSOCLEAR product for age-related macular degeneration and Stargardt’s macular degeneration through Phase I clinical trials. This product would be the first clinical candidate based on the SENS […]